Compare FOIL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Londian Wason New Energy Tech Inc. American Depositary Shares each representing five Ordinary Shares
Current Price
Current Price
| Metric | FOIL | ICLR |
|---|---|---|
| Founded | N/A | 1990 |
| Country | | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.3B |
| IPO Year | 2024 | 2001 |
| Metric | FOIL | ICLR |
|---|---|---|
| Price | $21.41 | $172.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $178.62 |
| AVG Volume (30 Days) | 29.8K | ★ 532.6K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.00 | $66.57 |
| 52 Week High | $25.44 | $203.91 |
| Indicator | FOIL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 49.24 |
| Support Level | $21.97 | $162.06 |
| Resistance Level | $23.13 | $183.11 |
| Average True Range (ATR) | 0.92 | 5.66 |
| MACD | 0.05 | -0.90 |
| Stochastic Oscillator | 53.48 | 34.81 |
Londian Wason New Energy Tech Inc is engaged in the research, development, and manufacture of electrolytic copper foil. Its product portfolio includes lithium-ion battery (LiB) copper foil, printed circuit board (PCB)-grade copper foil, and flexible copper clad laminates (FCCLs). Its products are used in applications including electric vehicles, energy storage systems, communication equipment, and consumer electronics. The company derives its revenue from contracts with customers, including the sales of LiB copper foil, PCB-grade copper foil and others in the PRC.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.